Biceltis 440mg | Lapatinib | MHP
BICELTIS 440MG DESCRIPTION Biceltis 440mg injection be expressed by a targeted cancer drug known as Trastuzumab, which is Pharmacologically classify as humanized monoclonal antibody produced by recombinant DNA technology. Biceltis 440mg helps to decrease the rate of reactivation & mortality. One of the epidermal growth factor receptors is known as human epidermal growth factor receptor 2 (HER2) plays vital role in breast cancer. This factor is responsible for cell replication. An FDA approved product Biceltis 440mg which is involved in breast cancer treatment. Biceltis 440mg vial with 858mg of lyophilized powder containing 440mg of Trastuzumab. gastri cancer breast cancer INDICATION The drug Biceltis 440mg injection is used for the treatment of Supportive treatment for breast cancer The drug Biceltis 440mg injection is used for the treatment of Advanced breast cancer The drug Biceltis 440mg injection is used for the treatment of Advanced gastric...